Delivery Systems for Substance Abuse Treatment: Russian Federation Marina Tsoy, M.D. Pavlov Medical University, St. Petersburg, Russia Istanbul, Turkey.

Slides:



Advertisements
Similar presentations
Characteristics of Health Care in Limited Access Territories.
Advertisements

Russia Federation, : from a policy on illegal drugs to a policy on psychoactive substances Dr. Konstantin Kharabet, professor of criminal law.
Drug Abuse and Social Work
Copyright © 2008 Delmar. All rights reserved. Chapter 27 The Homeless Population.
OLCC Agency Overview Steve Marks, Executive Director December 16.
Central Receiving Center Update (CRC) 5 Years of Operation June 10, 2008.
“Humanitarian Action” The Saint-Petersburg Charitable Foundation for Medical and Social Programs HAF.
1 Description of the addiction service of the Republic of Uzbekistan Jur’at Umargaliev Ministry of Health.
California Department of Public Health Office of AIDS Access to Sterile Syringes: Changes to California Law Alessandra Ross, MPH InjectionUse Specialist.
Focus Area 26: Substance Abuse Progress Review October 13, 2004.
3rd Baltic Conference on Medicines Economic Evaluation, Reimbursement and Rational Use of Pharmaceuticals Pricing and Reimbursement of Pharmaceuticals.
Substance Abuse Treatment. PROFILE OF A DRUG ABUSER  MOST PEOPLE IN TREATMENT ARE BETWEEN YEARS OF AGE  MANY DRUG ABUSERS SUFFER FROM MENTAL HEALTH.
Government of Moscow Moscow Department of Public Health Moscow Research and Practical Center on Addictions Drug demand reduction in RUSSIAN FEDERATION.
WORK PACKAGE TREATMENT CHALLENGES Dr.Thomas Legl Member of Executive Committee EURO –TC Director Kur- und Gesundheitszentrum Knappenhof/Austria ICAA,,
Behavioral Interventions for HIV Risk Reduction and HIV Prevention: An International Perspective Marek C. Chawarski Yale University School of Medicine.
SUBSTANCE USE DISORDERS GENERAL METHODS OF TREATMENT Inpatient Detoxification and Rehabilitation Outpatient Individual, Couple, or Family Counseling Self-help.
Mental Health and Substance Abuse Services Joe Vesowate Assistant Commissioner.
Polydrug use challenges – European experience International Conference: New trends in drug use: facts and solutions, Parliament of the Republic of Vilnius.
According to The National Center on Addiction and Substance Abuse at Columbia University.
TOBACCO PREVENTION AND CONTROL PROGRAM Mike Maples, Assistant Commissioner Mental Health and Substance Abuse Services.
Overview of Drug Control in Foreign Countries. Drug Control in EU A. Policy Trends ■ Decriminalisation of possession of small amount of drugs for personal.
Healthcare Delivery System
Addiction Treatment as HIV Prevention Charles P. O’Brien, MD, PhD David Metzger, PhD George E. Woody, MD University of Pennsylvania Treatment Research.
Arash Ghodousi Addiction Therapy 2015 Florida, USA August 03-08, 2015.
Continue Increasing Taxes on Alcohol. Background  Injuries  Liver diseases  Cancers  Heart diseases  Premature deaths  Poverty  Family and partner.
Delivery system for Substance Abuse Treatment: Ukraine Anatoliy M. Viyevskiy, M.D., Ph. D. The Head Narcologist of The MoH of Ukraine Istanbul, Turkey.
Delivery Systems for Substance Abuse Treatment: THE HASHEMITE KINGDOM OF JORDAN Dr. Jamal Anani Director of National Centre for Rehabilitation of Addicts.
© 2009 McGraw-Hill Higher Education. All rights reserved. Drug Products and Their Regulations.
HIGH POINT TREATMENT CENTER High Point Treatment Center’s (H.P.T.C.) mission is to prevent and treat chemical dependency and provide therapeutic services.
Delivery Systems for Substance Abuse Treatment: Integration with Primary Care and Mental Health and Social Services (Also referred to as) Delivery Systems.
Chapter 15: Substance-Related Disorders and Addictive Behaviors Copyright © 2012, 2007 Mosby, Inc., an affiliate of Elsevier Inc. All rights reserved.
Module 1 General introduction to substitution treatment.
© Copyright 2011, Pearson Education, Inc. All rights reserved. Chapter 2 Drug-Taking Behavior: The Personal and Social Concerns.
Chapter 3 Community Prevention Partnerships and Collaborations.
Epidemiology of addictive disorders: a brief review MRCPsych addiction psychiatry seminar series Dr Stuart McLaren 2 nd March 2012.
ADDICTIONS, EXPERIENCES AND LESSONS LEARNED YUKON SUBSTANCE USE PROBLEMS AND YUKON SOLUTIONS.
1 December 8, 2015 Crista M. Taylor, LCSW-C Director, Information, Planning and Development Adrienne Breidenstine, MSW Director of Opioid Overdose Prevention.
ADTRU National Alcohol Policy and Programs in Australia John B Saunders MD, FRACP Professor of Alcohol and Drug Studies, University of Queensland, Director,
Healthcare Delivery System Foundation Standard Understand the healthcare delivery system (public, private, government and non-profit)
Delivery Systems for Substance Abuse Treatment in MAURITIUS. DR. FAYZAL SULLIMAN COORDINATOR MEDICAL & RESEARCH UNIT NATReSA.
By Fred Kigozi M.D WPA Zone 14 Representative/ President Uganda Psychiatric Association, Director Butabika Hospital or
What is it? What causes it? What can we do about it?
Delivery Systems for Substance Abuse Treatment Country Presentation - Slovakia Lubomir Okruhlica, M.D., Ph.D. Institute on Drug Dependencies, CTDD Bratislava.
Gaza, Sept Substance Abuse Research Center 1 Delivery Systems for Substance Abuse Treatment: Gaza and the West Bank (Palestine Territory) Mohammed.
Overview of KP Behavioral Health Delivery System Dr. Stuart Buttlaire Regional Director of Inpatient Psychiatry and Continuing Care Regional Chair, Integrated.
Recent Developments in Substance Contorl Policy in the Russian Federation (based on offcical medical statistics) Konstantin Vyshinsky Ph.D., Leading Researcher.
1 READY BY 21 TASKFORCE Harford County Department of Community Services Local Management Board Health Benchmark December 7, 2010.
Prevalence of Alcoholism and Anti-Alcohol Policy in the Russian Federation Eugenia Koshkina Director National Research Center on Addictions Ministry of.
There is Hope. Scary Statistics Substance MalesFemales Any Drug Cocaine Marijuana Opiates Methamp hetamine PCP.
Alcohol Control Policy and Harm Done by Alcohol in Lithuania Riga, 2007 Audrius Ščeponavičius Director of the Public Health Department Ministry of Health.
Alcohol in Europe Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe.
Peculiarities of alcoholism prevalence in Russia and measures to reduce alcohol abuse Eugenia A. Koshkina Director, National Research Center on Addictions,
Medical Drugs, Intoxication Substances, and Somatic Diseases Evgeniya Koshkina Deputy Director for Science Moscow Research and Practical Centre on Addictions.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
“United Society” Foundation. General characteristics of the alcohol situation in Russia At the official level, alcohol consumption 14,0-14,5 liters per.
«Population Matters in the Russian Federation» FIRST Deputy Minister of Labour and Social Protection of the Russian Federation Sergey F. VELMYAYKIN.
Substance Abuse By: Joe Gonzalez & Danielle Lyner.
RECENT DEVELOPMENTS IN THE FIELD OF ALCOHOL AND SUBSTANCE ABUSE POLICY RUSSIAN FEDERATION.
Design of a Project “Detecting Patients with Alcohol Problems in the General Medical Network and Analysis of Forms and Methods of Specialized Care Provision”
New developments in alcohol and drug policy of the Russian Federation
Proposition 64 County Behavioral Health Directors Association
Koshkina E.A., Smirnovskaya M.S.
Drug Trends in Sweden 2017 Figures 1–
Change in legislation on alcohol, tobacco and drugs in Russia in 2016.
Proposition 64 County Behavioral Health Directors Association
Module 1: Putting Drugs of Abuse and Clients in Perspective
outpatient drug or alcohol clinic, mental health or community health center, private mental health professional, in-home counseling or crisis services,
Federal Research Institute for Health Organization and Informatics of Ministry of Health of the Russian Federation Policy and substance use among adolescents.
Alcohol and Drug Policy Changes in Russia – 2019
Presentation transcript:

Delivery Systems for Substance Abuse Treatment: Russian Federation Marina Tsoy, M.D. Pavlov Medical University, St. Petersburg, Russia Istanbul, Turkey September 2005

Russian Federation  Capital:Moscow  Estimated population: 145,200,000  World’s largest country by size

Russian Federation

General Overview Continued  Population145,200,000  Birth Rate10.3 births per 1000  Death rate16.52 deaths per 1000  Life Expectancyfor men 58.8 years for women 72.2 years  Age Structure0-14 years 18% years61% >65 years21%

Distribution for Major Religions  Russian Orthodox 80%  Muslim9 %  Buddhist3%  Others8%

Nationalities  Russians 80 %  Other nationalities with population more than 1,000,000:  Ukranians  Tatars  Bashkirs  Chuvashs  Chechens  Armenians

Economy  Labor Force:89,000,000 (61% of all population)  Unemployment Rate:7.9 %  Major Industries: petroleum, gas, weaponry, steel, aerospace, chemical, lumber and mining

The most important substance abuse problems  Alcohol  Tobacco  Inhalants (glue, solvents)  Heroin  Marijuana  Ecstasy  Amphetamine

Approximate ratio of registered drug users in 2003, per 100,000  Alcoholism:  Heroin dependence: 241  Hospitalized with alcohol psychosis: 35  Hospitalized with acute drug intoxication: 35.1

Substance Abuse Related Problems  Living with HIV/AIDS (by May 05)316,642  HIV/AIDS related deaths 979  (7 319 deaths of HIV-infected)  The most urgent substance-related problems include co-morbid infectious (HIV/AIDS, hepatitis, tuberculosis) and psychiatric disorders, adolescent substance abuse.

Co-morbidity of substance related problems and infectious diseases

Available Substance Abuse Treatment  Inpatient Detox  Outpatient Detox  Physician Counseling  Residential Rehabilitation  Other pharmacotherapies, including antabuse, naltrexone and nicotine replacement  Therapeutic Communities  Treatment for Women  Faith/Religion-based treatment  Treatment in Jail  Adolescent treatment  Psychotherapy  Outpatient Counseling Substitutive pharmacotherapy is prohibited by law

Treatment System History Treatment System History  Anti-alcohol legislation  1972 The decree of the Council of Ministers of USSR on improvement of anti-alcoholism measures, creation of specialized narcological service, education of professionals in the area of substance dependence  1985 Anti-alcoholism bill  1991 Licensing of liquor sales to private businesses  1997 Drug control bill, establishment of the Agency for control of drug sales  2003 Federal Drug control agency of Russian Federation

Anti-alcoholism campaign in Gorbachev era ( ) Anti-alcoholism bill Anti-alcoholism bill Decrease of production of alcohol beverages Decrease of production of alcohol beverages Decrease of sales of alcohol beverages Decrease of sales of alcohol beverages Increase of liquor prices Increase of liquor prices Introduction of age limit for alcohol buyers to 21 years Introduction of age limit for alcohol buyers to 21 years Introduction and enforcement of mandatory medical treatment of alcoholism Introduction and enforcement of mandatory medical treatment of alcoholism

Anti-alcoholism campaign in Gorbachev era (continued) Positive aspects Positive aspects Decrease of alcohol consumption per capita: Decrease of alcohol consumption per capita: liters/person/year liters/person/year (maximum safe limits – 8 liters/person/year, WHO Chronicles, 1983) WHO Chronicles, 1983) Decrease of alcoholism-related death rate Decrease of alcoholism-related death rate Decrease of alcohol-related crime rate Decrease of alcohol-related crime rate Decrease of number of alcohol psychoses Decrease of number of alcohol psychoses Decrease of divorce rate Decrease of divorce rate

Anti-alcoholism campaign in Gorbachev era (continued) Negative aspects Negative aspects Increased volume of inhalants use (glue, solvents) Increased volume of inhalants use (glue, solvents) Increase in production of home-brewed low quality (toxic) liquors Increase in production of home-brewed low quality (toxic) liquors These liquors accelerated the development of alcohol dependence These liquors accelerated the development of alcohol dependence These liquors were responsible for toxic-related complications and contributed to the sharp increase in death rate in years of These liquors were responsible for toxic-related complications and contributed to the sharp increase in death rate in years of

Federal Drug Control Agency Federal Drug Control Agency  Reports directly to the President of Russian Federation  Has federal enforcement authority  Relies on a number of regional offices  Has the following responsibilities:  Controls the distribution of narcotic and psychotropic substances  Battles illegal sales of narcotic and psychotropic substances  Participates in creation of and enforces the federal policy of distribution of controlled substances  Participates in creation and maintenance of the centralized database of distribution of controlled substances  Collaborates with international organizations and foreign law enforcement agencies in combating of illegal distribution of controlled substances  Represents Russian federation in the international organizations related to combating illegal distribution of controlled substances

Funding for Treatment  Substance abuse treatment is partially covered by the free, government-issued insurance (emergency cases – alcohol psychosis, acute intoxication, treatment for substance abuse in registered patients)  Anonymous treatment is always fully covered by the patient  Faith/religious organizations provide treatment in religious rehabilitation centers

Major issues in substance abuse treatment Insufficient availability of preventive programs Insufficient availability of preventive programs Adolescent beer-induced alcoholism Adolescent beer-induced alcoholism Social stigmatization of registered persons with alcoholism or drug dependence Social stigmatization of registered persons with alcoholism or drug dependence Prohibition of substitutive pharmacotherapy Prohibition of substitutive pharmacotherapy Limited availability of harm reduction treatment Limited availability of harm reduction treatment

Alcohol abuse in adolescence Average age of first alcohol use is 13 years Average age of first alcohol use is 13 years Among ages of 12 to 22 ~82% drink alcohol Among ages of 12 to 22 ~82% drink alcohol Frequency of alcoholism among teenagers is 10.5 in 10,000 Frequency of alcoholism among teenagers is 10.5 in 10,000 Major issues: Major issues: Beer is advertised as a “self-expression” drink for teenagers Beer is advertised as a “self-expression” drink for teenagers No age restrictions for beer sale No age restrictions for beer sale Unrestricted 24/7 availability of liquors Unrestricted 24/7 availability of liquors

Successful techniques in pharmacotherapy (research conducted at the St. Petersburg Pavlov Medical University) Double-blind placebo controlled study “Use of naltrexone, fluoxetine and their combination in stabilization of remission in heroin dependent patients” Double-blind placebo controlled study “Use of naltrexone, fluoxetine and their combination in stabilization of remission in heroin dependent patients” Four randomized groups (N=280): 1. Naltrexone + Fluoxetine 2. Naltrexone + Placebo 3. Placebo + Fluoxetine 4. Placebo + Placebo

 Naltrexone is effective for stabilization of remissions in heroin dependent patients  Combination of naltrexone and SSRI`s is more effective for heroin abuse treatment in women  Naltrexone compliance in the present study is much higher than in comparable foreign studies. This is attributed to the fact that heroin dependents in Russia are much younger and live with their relatives, who can enforce naltrexone use

Prospectives in pharmacotherapy of drug abuse New combinations: Naltrexone + glutamate NMDA receptor antagonist Memantine Naltrexone + glutamate NMDA receptor antagonist Memantine Naltrexone + alfa-2-adrenoreceptor agonist Lofexidine Naltrexone + alfa-2-adrenoreceptor agonist Lofexidine New formulations: Prolonged injectable naltrexone-depot Prolonged injectable naltrexone-depot